{
  "nctId": "NCT05326815",
  "briefTitle": "A Comparison of Serum and Urine N-telopeptide Marker",
  "officialTitle": "A Comparison of Serum and Urine N-telopeptide Marker",
  "protocolDocument": {
    "nctId": "NCT05326815",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2021-09-25",
    "uploadDate": "2023-10-27T10:54",
    "size": 316370,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT05326815/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 54,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2022-06-23",
    "completionDate": "2023-10-27",
    "primaryCompletionDate": "2023-03-15",
    "firstSubmitDate": "2022-03-28",
    "firstPostDate": "2022-04-14"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Consent to participate in the study\n* Participants limited to subjects in the CCF\n* Age between and inclusive of 18 and 85 years of age\n* No gender exclusion\n* Patients diagnosed with Osteopenia on DEXA scan who have not been on any medical therapy in the past\n* Presence of normal vitamin D levels, kidney function, and parathyroid hormone levels (per our reference ranges)\n\nExclusion Criteria:\n\n* Prior history of medical therapy for osteopenia\n* Prior radiation therapy\n* Prior history of bone fracture\n* History of high risk medication associated with increased risk of fracture\n* Presence of abnormal vitamin D levels, kidney function, and parathyroid hormone\n* Pregnancy status (verbal)\n* Those with medical co-morbidities that increase the risk of fracture will be excluded and these include but are not limited to: rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, diabetes mellitus, hyperparathyroidism, chronic kidney disease, pituitary disease, multiple myeloma, leukemia, lymphoma, thalassemia major, HIV/AIDS, malabsorption, Inflammatory bowel disease, chronic obstructive pulmonary disease, hypogonadism, chronic liver disease, untreated hyperthyroidism, and those with chronic immobility",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "85 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Correlation Between NTX Measures With Each Other",
        "description": "Correlation between NTX measures with each other",
        "timeFrame": "1 day (single visit lab test)"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 1
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 29,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:01.854Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}